Remozen-V Tablet
Salt Composition
Remogliflozin Etabonate (100mg) + Vildagliptin (50mg)
Key Information
Short Description
Remozen-V Tablet is a combination of two medicines used in the treatment of type 2 diabetes mellitus to improve glycemic control.
Dosage Form
Tablet
Introduction
Remozen-V Tablet is a combination of two medicines used in the treatment of type 2 diabetes mellitus. It is approved for use in adults aged 18 years and older to improve glycemic control. It is generally used when other diabetes medicines do not provide adequate glycemic control.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Remozen-V Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety Information
Side Effects
No common side effects listed.
How it works
Remozen-V Tablet is a combination of two anti-diabetic medicines: Remogliflozin Etabonate and Vildagliptin. Remogliflozin Etabonate works by removing excess sugar from your body through urine. Vildagliptin works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and post meal sugar levels.
Quick Tips
Remozen-V Tablet is prescribed to control blood sugar and avoid long-term complications. Take it after you have eaten a meal or with a snack to reduce the chance of an upset stomach. It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Always carry some sugary food or fruit juice with you in case you experience hypoglycemia (low blood sugar) symptoms such as fatigue, dizziness, cold sweats, tremor, and anxiety. It may cause your body to lose too much fluid (dehydration) or you may urinate more often. Drink plenty of water and stay hydrated.
Related Medicines
